Pharmaceutical Glass Tubing Market
PUBLISHED: 2025 ID: SMRC29489
SHARE
SHARE

Pharmaceutical Glass Tubing Market

Pharmaceutical Glass Tubing Market Forecasts to 2032 - Global Analysis By Glass Type (Borosilicate Glass (Type I), Soda-Lime Glass (Types II & III), and Other Glass Types), Manufacturing Process, Form, Distribution Channel, Application, End Users and By Geography

4.5 (60 reviews)
4.5 (60 reviews)
Published: 2025 ID: SMRC29489

Due to ongoing shifts in global trade and tariffs, the market outlook will be refreshed before delivery, including updated forecasts and quantified impact analysis. Recommendations and Conclusions will also be revised to offer strategic guidance for navigating the evolving international landscape.
Loading...

Years Covered

2024-2032

Estimated Year Value (2025)

US $16.09 BN

Projected Year Value (2032)

US $24.04 BN

CAGR (2025-2032)

5.9%

Regions Covered

North America, Europe, Asia Pacific, South America, and Middle East & Africa

Countries Covered

US, Canada, Mexico, Germany, UK, Italy, France, Spain, Japan, China, India, Australia, New Zealand, South Korea, Rest of Asia Pacific, South America, Argentina, Brazil, Chile, Middle East & Africa, Saudi Arabia, UAE, Qatar, and South Africa

Largest Market

Asia Pacific

Highest Growing Market

North America


According to Stratistics MRC, the Global Pharmaceutical Glass Tubing Market is accounted for $16.09 billion in 2025 and is expected to reach $24.04 billion by 2032 growing at a CAGR of 5.9% during the forecast period. Pharmaceutical glass tubing is a specialized type of glass used in the production of containers for storing and delivering medications. Made primarily from borosilicate or soda-lime glass, it offers high chemical resistance, thermal stability, and durability. This glass ensures the purity and safety of pharmaceutical products by preventing interactions with the container. It is commonly used to manufacture vials, ampoules, and syringes in the pharmaceutical and biotechnology industries.

Market Dynamics: 

Driver: 

Rising investment in healthcare infrastructure

The increasing demand for high-quality pharmaceutical packaging is driving investment in healthcare infrastructure globally. Governments and private entities are focusing on improving drug storage and delivery systems to ensure safety and efficacy. Advanced pharmaceutical glass tubing provides superior chemical resistance and minimizes contamination risks, making it a preferred choice. Technological innovations in tubing materials enhance durability and support efficient drug administration methods. Additionally, the rising prevalence of chronic diseases is fuelling investments in improved medical packaging solutions.

Restraint:

Risk of glass delamination

Glass delamination, a phenomenon where thin layers peel away from the internal surface of a vial, poses a significant challenge to pharmaceutical packaging. This issue can lead to compromised drug stability and potential health risks for patients. Manufacturers must implement rigorous quality control measures to mitigate these risks, increasing production costs. Additionally, the complexity of maintaining consistent glass quality across different formulations adds to the restraint in market expansion.

Opportunity:

Stringent regulatory standards for drug safety

Compliance with these standards ensures high-quality, contamination-free packaging driving demand for advanced glass tubing solutions. Specialized coatings and improved glass compositions help pharmaceutical companies meet stringent safety requirements. As the focus on biologics and injectable drugs grows, the need for reliable and durable glass tubing rises. Companies investing in research and development to enhance product integrity are gaining a competitive edge in the market. 

Threat:

Limited recycling and sustainability challenges

The complex composition of specialty glass makes recycling difficult, leading to environmental concerns. Manufacturers are exploring eco-friendly alternatives, but adoption remains slow due to cost and technical barriers. Additionally, the disposal of pharmaceutical glass waste must adhere to strict guidelines, further complicating sustainability efforts. Companies are under pressure to develop greener solutions while maintaining product efficacy and regulatory compliance.

Covid-19 Impact

The COVID-19 pandemic significantly influenced the pharmaceutical glass tubing market, both positively and negatively. Increased demand for vaccine packaging led to a surge in glass tubing production, boosting market growth. However, supply chain disruptions and raw material shortages caused delays in manufacturing and distribution. The pandemic underscored the importance of reliable pharmaceutical packaging for drug stability and safety. Companies have since focused on enhancing production efficiency to meet future healthcare crises.

The clear tubing segment is expected to be the largest during the forecast period

The clear tubing segment is expected to account for the largest market share during the forecast period, due to its transparency and chemical stability. Clear tubing facilitates easy drug inspection, ensuring quality control and safety for injectable medicines. Manufacturers prefer clear tubing for its compatibility with various formulations, reducing contamination risks. The growing adoption of biologic drugs and vaccines is further propelling demand for this segment. 

The hospital & diagnostic centers segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the hospital & diagnostic centers segment is predicted to witness the highest growth rate, due to the increasing number of healthcare facilities and diagnostic labs is driving the need for reliable drug packaging solutions. Advancements in medical treatments, including precision therapies, require high-quality glass tubing for drug delivery. The emphasis on patient safety and drug efficacy further strengthens demand within this segment. Additionally, hospital expansions and government healthcare initiatives support sustained market growth.

Region with largest share:

During the forecast period, the Asia Pacific region is expected to hold the largest market share driven by robust healthcare infrastructure and rising pharmaceutical production. Countries like China, India, and Japan have established themselves as key players in drug manufacturing and packaging innovation. Government policies promoting healthcare advancements are fuelling market growth across the region. The presence of leading pharmaceutical glass tubing manufacturers enhances supply chain efficiency and affordability.

Region with highest CAGR:

Over the forecast period, the North America region is anticipated to exhibit the highest CAGR, propelled by strict regulatory standards and technological advancements. The growing focus on biologics and injectable drugs is driving demand for superior glass tubing materials. Pharmaceutical companies in the U.S. and Canada are heavily investing in innovative packaging solutions to enhance drug stability. Rising healthcare expenditure and stringent drug safety requirements further accelerate market expansion.

Key players in the market

Some of the key players profiled in the Pharmaceutical Glass Tubing Market include Schott AG, Gerresheimer AG, Nipro Corporation, SGD Pharma, Stevanato Group S.p.A., West Pharmaceutical Services, Inc., Corning Incorporated, DWK Life Sciences GmbH, Ardagh Group S.A., Bormioli Pharma S.p.A., Piramal Glass Private Limited, Shandong Weigao Group Medical Polymer Products Co., Ltd., Nihon Yamamura Glass Co., Ltd., Amino GmbH, and Richland Glass Company, Inc.

Key Developments:

In May 2025, SCHOTT Pharma, announced that TPG, a leading global alternative asset management firm, has entered into a binding agreement to acquire a 35% stake in its joint venture SCHOTT Poonawalla from Serum Institute of India (SII). SCHOTT Poonawalla is a joint venture of SCHOTT Pharma and SII, part of the Cyrus Poonawalla Group and a global leader in vaccine manufacturing, dedicated to providing affordable vaccines worldwide.

In November 2024, SGD Pharma expands capacity of siliconized glass vials with the announcement of a new siliconization line at its Center of Excellence for Type I glass in France. The company enhances its already extensive range of in-house services by internalizing its glass siliconization offer, further ensuring responsiveness, security of supply and improved flexibility of vial sizes.

Glass Types Covered:
• Borosilicate Glass (Type I)
• Soda-Lime Glass (Types II & III)
• Other Glass Types

Manufacturing Processes Covered:
• Molded Glass Tubing
• Tubular Glass Tubing

Forms Covered:
• Clear Tubing
• Colored Tubing
• Frosted Tubing
• Other Forms

Distribution Channels Covered:
• Direct Sales
• Distributors
• Online Channels

Applications Covered:
• Vials
• Ampoules
• Cartridges
• Syringes
• Test Tubes
• Bottles
• Other Applications

End Users Covered:
• Pharmaceutical Manufacturers
• Contract Manufacturing Organizations (CMOs)
• Biotechnology Companies
• Hospital & Diagnostic Centers
• Research & Development Labs
• Other End Users

Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan        
o China        
o India        
o Australia  
o New Zealand
o South Korea
o Rest of Asia Pacific    
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa 
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa

What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2022, 2023, 2024, 2026, and 2030
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

Free Customization Offerings: 
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
o Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary       
         
2 Preface
       
 2.1 Abstract       
 2.2 Stake Holders      
 2.3 Research Scope      
 2.4 Research Methodology     
  2.4.1 Data Mining     
  2.4.2 Data Analysis     
  2.4.3 Data Validation     
  2.4.4 Research Approach     
 2.5 Research Sources      
  2.5.1 Primary Research Sources    
  2.5.2 Secondary Research Sources    
  2.5.3 Assumptions     
         
3 Market Trend Analysis      
 3.1 Introduction      
 3.2 Drivers       
 3.3 Restraints      
 3.4 Opportunities      
 3.5 Threats       
 3.6 Application Analysis     
 3.7 End User Analysis      
 3.8 Emerging Markets      
 3.9 Impact of Covid-19      
         
4 Porters Five Force Analysis      
 4.1 Bargaining power of suppliers     
 4.2 Bargaining power of buyers     
 4.3 Threat of substitutes     
 4.4 Threat of new entrants     
 4.5 Competitive rivalry      
         
5 Global Pharmaceutical Glass Tubing Market, By Glass Type   
 5.1 Introduction      
 5.2 Borosilicate Glass (Type I)     
 5.3 Soda-Lime Glass (Types II & III)    
 5.4 Other Glass Types      
         
6 Global Pharmaceutical Glass Tubing Market, By Manufacturing Process  
 6.1 Introduction      
 6.2 Molded Glass Tubing     
 6.3 Tubular Glass Tubing     
         
7 Global Pharmaceutical Glass Tubing Market, By Form   
 7.1 Introduction      
 7.2 Clear Tubing      
 7.3 Colored Tubing      
 7.4 Frosted Tubing      
 7.5 Other Forms      
         
8 Global Pharmaceutical Glass Tubing Market, By Distribution Channel  
 8.1 Introduction      
 8.2 Direct Sales      
 8.3 Distributors      
 8.4 Online Channels      
         
9 Global Pharmaceutical Glass Tubing Market, By Application   
 9.1 Introduction      
 9.2 Vials       
 9.3 Ampoules      
 9.4 Cartridges      
 9.5 Syringes       
 9.6 Test Tubes      
 9.7 Bottles       
 9.8 Other Applications      
         
10 Global Pharmaceutical Glass Tubing Market, By End User   
 10.1 Introduction      
 10.2 Pharmaceutical Manufacturers    
 10.3 Contract Manufacturing Organizations (CMOs)   
 10.4 Biotechnology Companies     
 10.5 Hospital & Diagnostic Centers     
 10.6 Research & Development Labs     
 10.7 Other End Users      
         
11 Global Pharmaceutical Glass Tubing Market, By Geography   
 11.1 Introduction      
 11.2 North America      
  11.2.1 US      
  11.2.2 Canada      
  11.2.3 Mexico      
 11.3 Europe       
  11.3.1 Germany      
  11.3.2 UK      
  11.3.3 Italy      
  11.3.4 France      
  11.3.5 Spain      
  11.3.6 Rest of Europe     
 11.4 Asia Pacific      
  11.4.1 Japan      
  11.4.2 China      
  11.4.3 India      
  11.4.4 Australia      
  11.4.5 New Zealand     
  11.4.6 South Korea     
  11.4.7 Rest of Asia Pacific     
 11.5 South America      
  11.5.1 Argentina     
  11.5.2 Brazil      
  11.5.3 Chile      
  11.5.4 Rest of South America    
 11.6 Middle East & Africa     
  11.6.1 Saudi Arabia     
  11.6.2 UAE      
  11.6.3 Qatar      
  11.6.4 South Africa     
  11.6.5 Rest of Middle East & Africa    
         
12 Key Developments       
 12.1 Agreements, Partnerships, Collaborations and Joint Ventures  
 12.2 Acquisitions & Mergers     
 12.3 New Product Launch     
 12.4 Expansions      
 12.5 Other Key Strategies     
         
13 Company Profiling       
 13.1 Schott AG      
 13.2 Gerresheimer AG      
 13.3 Nipro Corporation      
 13.4 SGD Pharma      
 13.5 Stevanato Group S.p.A.     
 13.6 West Pharmaceutical Services, Inc.    
 13.7 Corning Incorporated     
 13.8 DWK Life Sciences GmbH     
 13.9 Ardagh Group S.A.      
 13.10 Bormioli Pharma S.p.A.     
 13.11 Piramal Glass Private Limited     
 13.12 Shandong Weigao Group Medical Polymer Products Co., Ltd.  
 13.13 Nihon Yamamura Glass Co., Ltd.    
 13.14 Amino GmbH      
 13.15 Richland Glass Company, Inc.     
         
List of Tables        
1 Global Pharmaceutical Glass Tubing Market Outlook, By Region (2024-2032) ($MN) 
2 Global Pharmaceutical Glass Tubing Market Outlook, By Glass Type (2024-2032) ($MN) 
3 Global Pharmaceutical Glass Tubing Market Outlook, By Borosilicate Glass (Type I) (2024-2032) ($MN)
4 Global Pharmaceutical Glass Tubing Market Outlook, By Soda-Lime Glass (Types II & III) (2024-2032) ($MN)
5 Global Pharmaceutical Glass Tubing Market Outlook, By Other Glass Types (2024-2032) ($MN)
6 Global Pharmaceutical Glass Tubing Market Outlook, By Manufacturing Process (2024-2032) ($MN)
7 Global Pharmaceutical Glass Tubing Market Outlook, By Molded Glass Tubing (2024-2032) ($MN)
8 Global Pharmaceutical Glass Tubing Market Outlook, By Tubular Glass Tubing (2024-2032) ($MN)
9 Global Pharmaceutical Glass Tubing Market Outlook, By Form (2024-2032) ($MN) 
10 Global Pharmaceutical Glass Tubing Market Outlook, By Clear Tubing (2024-2032) ($MN)
11 Global Pharmaceutical Glass Tubing Market Outlook, By Colored Tubing (2024-2032) ($MN)
12 Global Pharmaceutical Glass Tubing Market Outlook, By Frosted Tubing (2024-2032) ($MN)
13 Global Pharmaceutical Glass Tubing Market Outlook, By Other Forms (2024-2032) ($MN)
14 Global Pharmaceutical Glass Tubing Market Outlook, By Distribution Channel (2024-2032) ($MN)
15 Global Pharmaceutical Glass Tubing Market Outlook, By Direct Sales (2024-2032) ($MN)
16 Global Pharmaceutical Glass Tubing Market Outlook, By Distributors (2024-2032) ($MN)
17 Global Pharmaceutical Glass Tubing Market Outlook, By Online Channels (2024-2032) ($MN)
18 Global Pharmaceutical Glass Tubing Market Outlook, By Application (2024-2032) ($MN)
19 Global Pharmaceutical Glass Tubing Market Outlook, By Vials (2024-2032) ($MN) 
20 Global Pharmaceutical Glass Tubing Market Outlook, By Ampoules (2024-2032) ($MN)
21 Global Pharmaceutical Glass Tubing Market Outlook, By Cartridges (2024-2032) ($MN)
22 Global Pharmaceutical Glass Tubing Market Outlook, By Syringes (2024-2032) ($MN)
23 Global Pharmaceutical Glass Tubing Market Outlook, By Test Tubes (2024-2032) ($MN)
24 Global Pharmaceutical Glass Tubing Market Outlook, By Bottles (2024-2032) ($MN) 
25 Global Pharmaceutical Glass Tubing Market Outlook, By Other Applications (2024-2032) ($MN)
26 Global Pharmaceutical Glass Tubing Market Outlook, By End User (2024-2032) ($MN)
27 Global Pharmaceutical Glass Tubing Market Outlook, By Pharmaceutical Manufacturers (2024-2032) ($MN)
28 Global Pharmaceutical Glass Tubing Market Outlook, By Contract Manufacturing Organizations (CMOs) (2024-2032) ($MN)
29 Global Pharmaceutical Glass Tubing Market Outlook, By Biotechnology Companies (2024-2032) ($MN)
30 Global Pharmaceutical Glass Tubing Market Outlook, By Hospital & Diagnostic Centers (2024-2032) ($MN)
31 Global Pharmaceutical Glass Tubing Market Outlook, By Research & Development Labs (2024-2032) ($MN)
32 Global Pharmaceutical Glass Tubing Market Outlook, By Other End Users (2024-2032) ($MN)
         
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.

List of Figures

RESEARCH METHODOLOGY


Research Methodology

We at Stratistics opt for an extensive research approach which involves data mining, data validation, and data analysis. The various research sources include in-house repository, secondary research, competitor’s sources, social media research, client internal data, and primary research.

Our team of analysts prefers the most reliable and authenticated data sources in order to perform the comprehensive literature search. With access to most of the authenticated data bases our team highly considers the best mix of information through various sources to obtain extensive and accurate analysis.

Each report takes an average time of a month and a team of 4 industry analysts. The time may vary depending on the scope and data availability of the desired market report. The various parameters used in the market assessment are standardized in order to enhance the data accuracy.

Data Mining

The data is collected from several authenticated, reliable, paid and unpaid sources and is filtered depending on the scope & objective of the research. Our reports repository acts as an added advantage in this procedure. Data gathering from the raw material suppliers, distributors and the manufacturers is performed on a regular basis, this helps in the comprehensive understanding of the products value chain. Apart from the above mentioned sources the data is also collected from the industry consultants to ensure the objective of the study is in the right direction.

Market trends such as technological advancements, regulatory affairs, market dynamics (Drivers, Restraints, Opportunities and Challenges) are obtained from scientific journals, market related national & international associations and organizations.

Data Analysis

From the data that is collected depending on the scope & objective of the research the data is subjected for the analysis. The critical steps that we follow for the data analysis include:

  • Product Lifecycle Analysis
  • Competitor analysis
  • Risk analysis
  • Porters Analysis
  • PESTEL Analysis
  • SWOT Analysis

The data engineering is performed by the core industry experts considering both the Marketing Mix Modeling and the Demand Forecasting. The marketing mix modeling makes use of multiple-regression techniques to predict the optimal mix of marketing variables. Regression factor is based on a number of variables and how they relate to an outcome such as sales or profits.


Data Validation

The data validation is performed by the exhaustive primary research from the expert interviews. This includes telephonic interviews, focus groups, face to face interviews, and questionnaires to validate our research from all aspects. The industry experts we approach come from the leading firms, involved in the supply chain ranging from the suppliers, distributors to the manufacturers and consumers so as to ensure an unbiased analysis.

We are in touch with more than 15,000 industry experts with the right mix of consultants, CEO's, presidents, vice presidents, managers, experts from both supply side and demand side, executives and so on.

The data validation involves the primary research from the industry experts belonging to:

  • Leading Companies
  • Suppliers & Distributors
  • Manufacturers
  • Consumers
  • Industry/Strategic Consultants

Apart from the data validation the primary research also helps in performing the fill gap research, i.e. providing solutions for the unmet needs of the research which helps in enhancing the reports quality.


For more details about research methodology, kindly write to us at info@strategymrc.com

Frequently Asked Questions

In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929

Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.

Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.

All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929

We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.

We have 3 different licensing options available in electronic format.

  • Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
  • 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
  • Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.

All our reports are typically be emailed to you as an attachment.

To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards.

We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.

Request Customization

We offer complimentary customization of up to 15% with every purchase.

To share your customization requirements, feel free to email us at info@strategymrc.com or call us on +1-301-202-5929. .

Please Note: Customization within the 15% threshold is entirely free of charge. If your request exceeds this limit, we will conduct a feasibility assessment. Following that, a detailed quote and timeline will be provided.

WHY CHOOSE US ?

Assured Quality

Assured Quality

Best in class reports with high standard of research integrity

24X7 Research Support

24X7 Research Support

Continuous support to ensure the best customer experience.

Free Customization

Free Customization

Adding more values to your product of interest.

Safe and Secure Access

Safe & Secure Access

Providing a secured environment for all online transactions.

Trusted by 600+ Brands

Trusted by 600+ Brands

Serving the most reputed brands across the world.

Testimonials